Sökning: (id:"swepub:oai:DiVA.org:uu-265812") >
eta-Secretase proce...
-
Willem, MichaelUniv Munich, Biomed Ctr BMC, D-81377 Munich, Germany.
(författare)
eta-Secretase processing of APP inhibits neuronal activity in the hippocampus
- Artikel/kapitelEngelska2015
Förlag, utgivningsår, omfång ...
-
2015-08-31
-
Springer Science and Business Media LLC,2015
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-265812
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-265812URI
-
https://doi.org/10.1038/nature14864DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-beta peptide(1). Two principal physiological pathways either prevent or promote amyloid-beta generation from its precursor, beta-amyloid precursor protein (APP), in a competitive manne(r)1. Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metabolism in vivo(2). Here we describe a new physiological APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus. We identify higher molecular mass carboxy-terminal fragments (CTFs) of APP, termed CTF-eta, in addition to the long-known CTF-alpha and CTF-beta fragments generated by the alpha- and beta-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (beta-site APP cleaving enzyme 1), respectively. CTF-eta generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, referred to as g-secretase activity. g-Secretase cleavage occurs primarily at amino acids 504-505 of APP(695), releasing a truncated ectodomain. After shedding of this ectodomain, CTF-eta is further processed by ADAM10 and BACE1 to release long and short A eta peptides (termed A eta-alpha and A eta-beta). CTFs produced by g-secretase are enriched in dystrophic neurites in an AD mouse model and in human AD brains. Genetic and pharmacological inhibition of BACE1 activity results in robust accumulation of CTF-eta and A eta-alpha. In mice treated with a potent BACE1 inhibitor, hippocampal long-term potentiation was reduced. Notably, when recombinant or synthetic A eta-alpha was applied on hippocampal slices ex vivo, long-term potentiation was lowered. Furthermore, in vivo single-cell two-photon calcium imaging showed that hippocampal neuronal activity was attenuated by A eta-alpha. These findings not only demonstrate a major functionally relevant APP processing pathway, but may also indicate potential translational relevance for therapeutic strategies targeting APP processing.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Tahirovic, SabinaGerman Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany.
(författare)
-
Busche, Marc AurelTech Univ Munich, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany.;Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany.;Univ Munich, Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.
(författare)
-
Ovsepian, Saak V.German Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany.
(författare)
-
Chafai, MagdaUniv Nice Sophia Antipolis, UMR 7275, CNRS, IPMC, F-06560 Valbonne, France.
(författare)
-
Kootar, ScherazadUniv Nice Sophia Antipolis, UMR 7275, CNRS, IPMC, F-06560 Valbonne, France.
(författare)
-
Hornburg, DanielMax Planck Inst Biochem, D-82152 Martinsried, Germany.
(författare)
-
Evans, Lewis D. B.Univ Cambridge, Gurdon Inst, Cambridge Stem Cell Inst, Cambridge CB2 1QN, England.;Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England.
(författare)
-
Moore, StevenUniv Cambridge, Gurdon Inst, Cambridge Stem Cell Inst, Cambridge CB2 1QN, England.;Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England.
(författare)
-
Daria, AnnaUniv Munich, Biomed Ctr BMC, D-81377 Munich, Germany.
(författare)
-
Hampel, HeikeUniv Munich, Biomed Ctr BMC, D-81377 Munich, Germany.
(författare)
-
Mueller, VeronikaUniv Munich, Biomed Ctr BMC, D-81377 Munich, Germany.
(författare)
-
Giudici, CamillaUniv Munich, Biomed Ctr BMC, D-81377 Munich, Germany.
(författare)
-
Nuscher, BrigitteUniv Munich, Biomed Ctr BMC, D-81377 Munich, Germany.
(författare)
-
Wenninger-Weinzierl, AndreaGerman Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany.
(författare)
-
Kremmer, ElisabethGerman Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany.;Univ Munich, Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.;German Res Ctr Environm Hlth, Inst Mol Immunol, D-81377 Munich, Germany.
(författare)
-
Heneka, Michael T.Univ Bonn, Clin Neurosci Unit, Dept Neurol, D-53127 Bonn, Germany.;German Ctr Neurodegenerat Dis DZNE Bonn, D-53175 Bonn, Germany.
(författare)
-
Thal, Dietmar R.Univ Ulm, Inst Pathol, Neuropathol Lab, D-89081 Ulm, Germany.
(författare)
-
Giedraitis, VilmantasUppsala universitet,Geriatrik(Swepub:uu)vigie517
(författare)
-
Lannfelt, LarsUppsala universitet,Geriatrik(Swepub:uu)lalan021
(författare)
-
Mueller, UlrikeHeidelberg Univ, Funct Genom, Inst Pharm & Mol Biotechnol IPMB, D-69120 Heidelberg, Germany.
(författare)
-
Livesey, Frederick J.Univ Cambridge, Gurdon Inst, Cambridge Stem Cell Inst, Cambridge CB2 1QN, England.;Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England.
(författare)
-
Meissner, FelixMax Planck Inst Biochem, D-82152 Martinsried, Germany.
(författare)
-
Herms, JochenGerman Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany.
(författare)
-
Konnerth, ArthurTech Univ Munich, Inst Neurosci, D-80802 Munich, Germany.;Univ Munich, Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.
(författare)
-
Marie, HeleneUniv Nice Sophia Antipolis, UMR 7275, CNRS, IPMC, F-06560 Valbonne, France.
(författare)
-
Haass, ChristianUniv Munich, Biomed Ctr BMC, D-81377 Munich, Germany.;German Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany.;Univ Munich, Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.
(författare)
-
Univ Munich, Biomed Ctr BMC, D-81377 Munich, Germany.German Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Nature: Springer Science and Business Media LLC526:7573, s. 443-4470028-08361476-4687
Internetlänk
Hitta via bibliotek
-
Nature
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Willem, Michael
-
Tahirovic, Sabin ...
-
Busche, Marc Aur ...
-
Ovsepian, Saak V ...
-
Chafai, Magda
-
Kootar, Scheraza ...
-
visa fler...
-
Hornburg, Daniel
-
Evans, Lewis D. ...
-
Moore, Steven
-
Daria, Anna
-
Hampel, Heike
-
Mueller, Veronik ...
-
Giudici, Camilla
-
Nuscher, Brigitt ...
-
Wenninger-Weinzi ...
-
Kremmer, Elisabe ...
-
Heneka, Michael ...
-
Thal, Dietmar R.
-
Giedraitis, Vilm ...
-
Lannfelt, Lars
-
Mueller, Ulrike
-
Livesey, Frederi ...
-
Meissner, Felix
-
Herms, Jochen
-
Konnerth, Arthur
-
Marie, Helene
-
Haass, Christian
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Geriatrik
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Neurovetenskaper
- Artiklar i publikationen
-
Nature
- Av lärosätet
-
Uppsala universitet